Curative received FDA emergency use authorization for its novel COVID-19 tests
Companies, agencies, institutions, etc
the Food and Drug Administration
FDA
RT
EUA
Korva Labs
CDC
Personal Protective Equipment
Curative Inc.
the Cities of Los Angeles
Sherrif’s Department
DCVC
Limited Partners
Harvard University
Business Insider
People
Denise Hinton
Fred Turner
William Hanage
Groups
UCLA.These
COVID-19
Physical locations
No matching tags
Places
the LA County Fire
Locations
the City of Los Angeles
US
Long Beach
LA County
Events
No matching tags
Summary
The diagnostics startup Curative has received an emergency use authorization from the Food and Drug Administration for its novel test to determine COVID-19 infection.The company says that its tests have already been used by the City of Los Angeles since late March and have tested over 53,000 city residents.Curative’s tests use an oral-fluid sample collected by having the subject cough to produce sputum, which release the virus from deep in the lungs, according to a spokesperson.Here’s how the letter digitally signed by the FDA’s chief science officer, Denise Hinton, describes the Curative test:To use your product, SARS-CoV-2 nucleic acid is first extracted, isolated and purified from oropharyngeal (throat) swab, nasopharyngeal swab, nasal swab, and oral fluid specimens.
As said here by Jonathan Shieber